ouabain has been researched along with 17-octadecynoic acid in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| An, SJ; Escalante, BA; Ferreri, NR; McGiff, JC; Zhao, Y | 1 |
| Escalante, B; López-Sánchez, P; Martínez-Ayala, S; Rios, A; Sánchez-Mendoza, A; Vázquez-Cruz, B | 1 |
| El-Mahmoudy, A; Matsuyama, H; Shimizu, Y; Takewaki, T; Thapaliya, S | 1 |
| Bełtowski, J; Górny, D; Marciniak, A; Wójcicka, G | 1 |
| Hollenberg, MD; Loutzenhiser, R; Wang, X | 1 |
5 other study(ies) available for ouabain and 17-octadecynoic acid
| Article | Year |
|---|---|
Angiotensin II induces TNF production by the thick ascending limb: functional implications.
Topics: Angiotensin II; Animals; Biological Transport; Dinoprostone; Fatty Acids, Unsaturated; Indomethacin; Kidney Medulla; Kidney Tubules; Loop of Henle; Male; Ouabain; Oxygen Consumption; Rats; Rats, Sprague-Dawley; RNA, Messenger; Rubidium Radioisotopes; Transcription, Genetic; Tumor Necrosis Factor-alpha | 1998 |
Angiotensin II modulates ion transport in rat proximal tubules through CYP metabolites.
Topics: Adrenalectomy; Angiotensin II; Animals; Arachidonic Acid; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dexamethasone; Dose-Response Relationship, Drug; Fatty Acids, Unsaturated; Hydroxyeicosatetraenoic Acids; Indomethacin; Ion Transport; Kidney Tubules, Proximal; Losartan; Male; Ouabain; Rats; Rats, Sprague-Dawley; Rubidium Radioisotopes | 2000 |
An endothelium-derived factor modulates purinergic neurotransmission to mesenteric arterial smooth muscle of hamster.
Topics: 4-Aminopyridine; Adenosine Triphosphate; Animals; Apamin; Biological Factors; Charybdotoxin; Cricetinae; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Epoprostenol; Fatty Acids, Unsaturated; Glyburide; In Vitro Techniques; Indomethacin; Male; Membrane Potentials; Mesenteric Arteries; Mesocricetus; Muscle, Smooth, Vascular; Neuromuscular Junction; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Ouabain; Pinacidil; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Synaptic Transmission; Tetraethylammonium; Time Factors; Triazines; Uridine Triphosphate; Vasodilator Agents | 2003 |
Regulation of renal Na(+),K(+)-ATPase and ouabain-sensitive H(+),K(+)-ATPase by the cyclic AMP-protein kinase A signal transduction pathway.
Topics: Animals; Brefeldin A; Bucladesine; Cell Membrane; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Fatty Acids, Unsaturated; H(+)-K(+)-Exchanging ATPase; Imidazoles; Kidney; Kidney Cortex; Kidney Medulla; Male; Ouabain; Rats; Rats, Wistar; Signal Transduction; Sodium-Potassium-Exchanging ATPase | 2003 |
Redundant signaling mechanisms contribute to the vasodilatory response of the afferent arteriole to proteinase-activated receptor-2.
Topics: Angiotensin II; Animals; Apamin; Arterioles; Charybdotoxin; Fatty Acids, Unsaturated; Kidney; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oligopeptides; Ouabain; Rats; Rats, Sprague-Dawley; Receptor, PAR-2; Signal Transduction; Sodium-Potassium-Exchanging ATPase; Tetraethylammonium; Trypsin; Vasodilation | 2005 |